Earnings8-K
Results of Operations and Financial Condition
Show detailsHide details
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
CRMD
Cormedix Inc.
A biopharmaceutical company that makes Defencath, a catheter lock solution used by kidney-dialysis patients to prevent bloodstream infections and blood clotting. Founded in 2006 by Antony P. Pfaffle, the firm began life as Picton Holding Company and was renamed CorMedix a few months later. The name blends the Latin "cor" (heart) with "medix," a nod to the medical conditions it addresses.
CUSIP: 21900C308HealthcareUS1 holder